These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
7. The effects of calcium supplementation to patients with primary hyperparathyroidism and a low calcium intake. Jorde R; Szumlas K; Haug E; Sundsfjord J Eur J Nutr; 2002 Dec; 41(6):258-63. PubMed ID: 12474069 [TBL] [Abstract][Full Text] [Related]
8. Clodronate in the medical management of hyperparathyroidism. Hamdy NA; Gray RE; McCloskey E; Galloway J; Rattenbury JM; Brown CB; Kanis JA Bone; 1987; 8 Suppl 1():S69-77. PubMed ID: 2961358 [TBL] [Abstract][Full Text] [Related]
9. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery. Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835 [TBL] [Abstract][Full Text] [Related]
10. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism. Jansson S; Tisell LE; Lindstedt G; Lundberg PA Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370 [TBL] [Abstract][Full Text] [Related]
11. Estrogens and progestins in the management of primary hyperparathyroidism. Marcus R J Bone Miner Res; 1991 Oct; 6 Suppl 2():S125-9; discussion S151-2. PubMed ID: 1763663 [TBL] [Abstract][Full Text] [Related]
12. [Cimetidine treatment of primary hyperparathyroidism]. Caron P; Gaillard J; Barousse C; Bouissou H; Louvet JP; Boulard C Ann Med Interne (Paris); 1984; 135(1):12-5. PubMed ID: 6322636 [TBL] [Abstract][Full Text] [Related]
13. Management of hyperparathyroidism in pregnancy with oral phosphate therapy. Montoro MN; Collea JV; Mestman JH Obstet Gynecol; 1980 Apr; 55(4):431-4. PubMed ID: 7366898 [TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates and primary hyperparathyroidism. Rodan GA J Bone Miner Res; 2002 Nov; 17 Suppl 2():N150-3. PubMed ID: 12412793 [TBL] [Abstract][Full Text] [Related]
15. Medical treatment of primary hyperparathyroidism: effects on parathormone and vitamin D metabolites. Foldes J; Halperin Y; Kidroni G; Menczel J Isr J Med Sci; 1987 Nov; 23(11):1148-51. PubMed ID: 3125129 [TBL] [Abstract][Full Text] [Related]
16. In vivo studies of parathyroid gland function in secondary hyperparathyroidism. Salusky IB; Goodman WG Adv Nephrol Necker Hosp; 1996; 25():289-302. PubMed ID: 8717632 [TBL] [Abstract][Full Text] [Related]